ABBV
Price:
$179.8
Market Cap:
$317.73B
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pan...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-01-02
Stock Exchange
NYSE
Ticker
ABBV
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current ROE is 65.72%. This represents a change of 269.59% compared to the average of 17.78% of the last 4 quarters.
The mean historical ROE of AbbVie Inc. over the last ten years is 52.68%. The current 65.72% ROE has changed 24.75% with respect to the historical average. Over the past ten years (40 quarters), ABBV's ROE was at its highest in in the March 2018 quarter at 78.33%. The ROE was at its lowest in in the September 2018 quarter at -94.04%.
Average
52.68%
Median
71.75%
Minimum
-96.45%
Maximum
130.39%
Discovering the peaks and valleys of AbbVie Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 112.20%
Maximum Annual ROE = 130.39%
Minimum Annual Increase = -164.64%
Minimum Annual ROE = -96.45%
Year | ROE | Change |
---|---|---|
2023 | 46.94% | -31.57% |
2022 | 68.60% | -8.42% |
2021 | 74.91% | 112.20% |
2020 | 35.30% | -136.60% |
2019 | -96.45% | 43.24% |
2018 | -67.33% | -164.64% |
2017 | 104.16% | -18.88% |
2016 | 128.41% | -1.52% |
2015 | 130.39% | 28.04% |
2014 | 101.84% | 10.82% |
The current ROE of AbbVie Inc. (ABBV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
63.48%
5-year avg
25.86%
10-year avg
52.68%
AbbVie Inc.’s ROE is less than Merck & Co., Inc. (29.27%), less than Pfizer Inc. (4.72%), less than Eli Lilly and Company (65.15%), greater than Bristol-Myers Squibb Company (-36.26%), less than Johnson & Johnson (20.94%), less than Amgen Inc. (68.49%), greater than Gilead Sciences, Inc. (0.65%),
Company | ROE | Market cap |
---|---|---|
29.27% | $251.57B | |
4.72% | $151.34B | |
65.15% | $755.34B | |
-36.26% | $117.15B | |
20.94% | $351.15B | |
68.49% | $142.17B | |
0.65% | $117.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AbbVie Inc.'s ROE?
How is the ROE calculated for AbbVie Inc. (ABBV)?
What is the highest ROE for AbbVie Inc. (ABBV)?
What is the 3-year average ROE for AbbVie Inc. (ABBV)?
What is the 5-year average ROE for AbbVie Inc. (ABBV)?
How does the current ROE for AbbVie Inc. (ABBV) compare to its historical average?